Hangzhou AGS MedTech Co., Ltd.

SHSE:688581 Voorraadrapport

Marktkapitalisatie: CN¥4.9b

HangzhouS MedTech Beheer

Beheer criteriumcontroles 1/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Cheng Zhang

Algemeen directeur

CN¥3.3m

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEO12.9yrs
Eigendom CEO40.1%
Management gemiddelde ambtstermijngeen gegevens
Gemiddelde ambtstermijn bestuurgeen gegevens

Recente managementupdates

Recent updates

An Intrinsic Calculation For Hangzhou AGS MedTech Co., Ltd. (SHSE:688581) Suggests It's 43% Undervalued

Oct 25
An Intrinsic Calculation For Hangzhou AGS MedTech Co., Ltd. (SHSE:688581) Suggests It's 43% Undervalued

There May Be Underlying Issues With The Quality Of HangzhouS MedTech's (SHSE:688581) Earnings

Apr 29
There May Be Underlying Issues With The Quality Of HangzhouS MedTech's (SHSE:688581) Earnings

Hangzhou AGS MedTech Co., Ltd. (SHSE:688581) Looks Inexpensive But Perhaps Not Attractive Enough

Apr 24
Hangzhou AGS MedTech Co., Ltd. (SHSE:688581) Looks Inexpensive But Perhaps Not Attractive Enough

CEO

Cheng Zhang (54 yo)

12.9yrs

Tenure

CN¥3,299,900

Compensatie

Mr. Cheng Zhang is Chairman & General Manager of Hangzhou AGS MedTech Co., Ltd. since December 2011.